Providence pioneering technology to help ALS patients breathe

01/16/2013

ALS – Amyotrophic Lateral Sclerosis or Lou Gehrig’s disease – is a devastating diagnosis. ALS causes progressive degeneration of nerve cells, and it can lead to complete paralysis and death. But a new device, implanted by Providence into the first patient in Oregon, can helping slow the disease’s threat to breathing, and possibly extend the quality of life for many people with ALS.

Hear the KPTV story with the first Oregonian to receive the diaphragm pacing system (DPS): Helping ALS patients breathe.

Image Here

International partnership with Bristol-Myers Squibb

Providence Cancer Center joins global collaboration, taking cancer treatment research to a new level. More »

Image Here

Clinical trial offers great hope for metastatic melanoma patients.

Cancer researchers study a unique approach, combining radiation and immunotherapy treatments. More »

Image Here

Connecting Oregon communities to stroke expertise

Telestroke puts stroke experts “in the room” 24/7. More »

News


Events